Cyclic adenosine-inosine monophosphate
Cyclic Adenosine-Inosine Monophosphate[edit | edit source]
Cyclic adenosine-inosine monophosphate (cAIMP) is a cyclic nucleotide derived from adenosine monophosphate (AMP) and inosine monophosphate (IMP). It is a member of the family of cyclic nucleotides, which are important intracellular signaling molecules.
Structure and Synthesis[edit | edit source]
Cyclic adenosine-inosine monophosphate is structurally similar to other cyclic nucleotides such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). The molecule consists of a phosphate group that forms a cyclic bond with the 3' and 5' hydroxyl groups of the ribose sugar, which is attached to the purine bases adenosine and inosine.
The synthesis of cAIMP involves the enzymatic conversion of AMP and IMP by specific adenylate cyclase enzymes. These enzymes catalyze the cyclization of the phosphate group, resulting in the formation of the cyclic structure.
Biological Function[edit | edit source]
Cyclic adenosine-inosine monophosphate functions as a secondary messenger in various biological processes. It is involved in the regulation of cell signaling pathways, influencing cellular responses to external stimuli. cAIMP can modulate the activity of protein kinases, which are enzymes that phosphorylate proteins, thereby altering their function and activity.
In particular, cAIMP plays a role in the regulation of immune responses, metabolism, and cell proliferation. It is also implicated in the modulation of neurotransmitter release and hormone secretion.
Role in Disease[edit | edit source]
Alterations in the levels of cyclic adenosine-inosine monophosphate have been associated with various diseases. Dysregulation of cAIMP signaling pathways can contribute to the pathogenesis of cancer, cardiovascular disease, and neurological disorders.
Research is ongoing to understand the precise mechanisms by which cAIMP influences disease processes and to explore its potential as a therapeutic target.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
